Advertisement

Biological Trace Element Research

, Volume 157, Issue 1, pp 1–8 | Cite as

Improved Meta-Analytic Methods Show No Effect of Chromium Supplements on Fasting Glucose

  • Christopher H. BaileyEmail author
Article

Abstract

The trace mineral chromium has been extensively researched over the years in its role in glucose metabolism. Dietary supplement companies have attempted to make claims that chromium may be able to treat or prevent diabetes. Previous meta-analyses/systematic reviews have indicated that chromium supplementation results in a significant lowering of fasting glucose in diabetics but not in nondiabetics. A meta-analysis was conducted using an alternative measure of effect size, d ppc2 in order to account for changes in the control group as well as the chromium group. The literature search included MEDLINE, the Cochrane Controlled Trials Register, and previously published article reviews, systematic reviews, and meta-analyses. Included studies were randomized, placebo-controlled trials in the English language with subjects that were nonpregnant adults, both with and without diabetes. Sixteen studies with 809 participants (440 diabetics and 369 nondiabetics) were included in the analysis. Screening for publication bias indicated symmetry of the data. Tests of heterogeneity indicated the use of a fixed-effect model (I 2 = 0 %). The analysis indicated that there was no significant effect of chromium supplementation in diabetics or nondiabetics, with a weighted average effect size of 0.02 (SE = 0.07), p = 0.787, CI 95 % = −0.12 to 0.16. Chromium supplementation appears to provide no benefits to populations where chromium deficiency is unlikely.

Keywords

Chromium Diabetes Meta-analysis dppc2 Fasting glucose 

Notes

Acknowledgments

I would like to thank Vanessa Perez, Ph.D., Soyeon Ahn, Ph.D., and William Bailey, Ph.D. for their comments and input on this manuscript.

References

  1. 1.
    Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, Zinman B (2007) Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 30(3):753–759. doi: 10.2337/dc07-9920 PubMedCrossRefGoogle Scholar
  2. 2.
    Diagnosis of diabetes and prediabetes. (2012) National Diabetes Information Clearinghouse. http://diabetes.niddk.nih.gov/dm/pubs/diagnosis/. Accessed January 2013
  3. 3.
    Dietary supplement fact sheet: chromium. (2005) Office of Dietary Supplements, National Institute of Health. http://ods.od.nih.gov/factsheets/Chromium-HealthProfessional/. Accessed January 2013
  4. 4.
    Hambidge KM, Rodgerson DO, O’Brien D (1968) Concentration of chromium in the hair of normal children and children with juvenile diabetes mellitus. Diabetes 17(8):517–519. doi: 10.2337/diab.17.8.517 PubMedGoogle Scholar
  5. 5.
    Qualified Health Claims: Letter of Enforcement Discretion - Chromium Picolinate and Insulin Resistance(Docket No. 2004Q-0144). (2005) U.S. Food and Drug Administration. http://www.fda.gov/Food/IngredientsPackagingLabeling/LabelingNutrition/ucm073017.htm. Accessed October 2013
  6. 6.
    Althuis MD, Jordan NE, Ludington EA, Wittes JT (2002) Glucose and insulin responses to dietary chromium supplements: a meta-analysis. Am J Clin Nutr 76(1):148–155PubMedGoogle Scholar
  7. 7.
    Anderson RA, Cheng N, Bryden NA, Polansky MM, Cheng N, Chi J, Feng J (1997) Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diab. Diabetes 46(11):1786–1791. doi: 10.2337/diabetes.46.11.1786 Google Scholar
  8. 8.
    Balk EM, Tatsioni A, Lichtenstein AH, Lau J, Pittas AG (2007) Effect of chromium supplementation on glucose metabolism and lipids: a systematic review of randomized controlled trials. Diabetes Care 30(8):2154–2163. doi: 10.2337/dc06-0996 PubMedCrossRefGoogle Scholar
  9. 9.
    Patal PC, Cardino MT, Jimeno CA (2010) A meta-analysis on the effect of chromium picolinate on glucose and lipid profiles among patients with type 2 diabetes mellitus. Philipp J Int Med 48(1):32–37Google Scholar
  10. 10.
    Abdollahi M, Farshchi A, Nikfar S, Seyedifar M (2013) Effect of chromium on glucose and lipid profiles in patients with type 2 diabetes; a meta-analysis review of randomized trials. J Pharm Pharmaceut Sci 16(1):99–114Google Scholar
  11. 11.
    Joseph LJ, Farrell PA, Davey SL, Evans WJ, Campbell WW (1999) Effect of resistance training with or without chromium picolinate supplementation on glucose metabolism in older men and women. Metabolism 48(5):546–553. doi: 10.1016/S0026-0495(99)90048-3 PubMedCrossRefGoogle Scholar
  12. 12.
    Grant KE, Chandler RM, Castle AL, Ivy JL (1997) Chromium and exercise training: effect on obese women. Med Sci Sports Exerc 29(8):992–998Google Scholar
  13. 13.
    Lefavi RG, Wilson GD, Keith RE, Anderson RA, Blessing DL, Hames CG, McMillan JL (1993) Lipid-lowering effect of a dietary chromium (III)-nicotinic acid complex in male athletes. Nutr Res 13(3):239–249. doi: 10.1016/S0271-5317(05)80421-X Google Scholar
  14. 14.
    Crawford V, Scheckenbach R, Preuss HG (1999) Effects of niacin-bound chromium supplementation on body composition in overweight African-American women. Diabetes Obes Metab 1(6):331–337. doi: 10.1046/j.1463-1326.1999.00055.x PubMedCrossRefGoogle Scholar
  15. 15.
    Borenstein M, Hedges LV, Higgins JPT, Rothstein HR (2010) A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods 1(2):97–111. doi: 10.1002/jrsm.12 CrossRefGoogle Scholar
  16. 16.
    Morris SB (2008) Estimating effect sizes from pretest-posttest-control group designs. Organ Res Methods 11(2):364–386. doi: 10.1177/1094428106291059 CrossRefGoogle Scholar
  17. 17.
    Aghdassi E, Arendt BM, Salit IE, Mohammed SS, Jalali P, Bondar H, Allard JP (2010) In patients with HIV-infection, chromium supplementation improves insulin resistance and other metabolic abnormalities: a randomized, double-blind, placebo controlled trial. Curr HIV Res 8(2):113–120PubMedCrossRefGoogle Scholar
  18. 18.
    Jain SK, Kahlon G, Morehead L, Dhawan R, Lieblong B, Stapleton T, Caldito G, Hoeldtke R, Levine SN, Bass PF 3rd (2012) Effect of chromium dinicocysteinate supplementation on circulating levels of insulin, TNF-alpha, oxidative stress, and insulin resistance in type 2 diabetic subjects: randomized, double-blind, placebo-controlled study. Mol Nutr Food Res 56(8):1333–1341. doi: 10.1002/mnfr.201100719 PubMedCrossRefGoogle Scholar
  19. 19.
    Król E, Krejpcio Z, Byks H, Bogdanski P, Pupek-Musialik D (2011) Effects of chromium brewer’s yeast supplementation on body mass, blood carbohydrates, and lipids and minerals in type 2 diabetic patients. Biol Trace Elem Res 143(2):726–737. doi: 10.1007/s12011-010-8917-5 PubMedCrossRefGoogle Scholar
  20. 20.
    Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Loannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6(7):1–28. doi: 10.1371/journal.pmed.1000100 CrossRefGoogle Scholar
  21. 21.
    Wallace BC, Dahabreh IJ, Trikalinos TA, Lau J, Trow P, Schmid CH (2012) Closing the gap between methodologists and end-users: R as a computational back-end. J Stat Softw 49(5):1–15Google Scholar
  22. 22.
    Viechtbauer W (2010) Conducting meta-analyses in R with the metafor package. J Stat Softw 36(3):1–48Google Scholar
  23. 23.
    R Core Team (2013) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, AustriaGoogle Scholar
  24. 24.
    IBM Corp (2012) SPSS Statistics for Mac, Version 21.0. IBM Corp, Armonk, NYGoogle Scholar
  25. 25.
    Egger M, George Davey S, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. Br Med J 315(7109):629–634. doi: 10.1136/bmj.315.7109.629 CrossRefGoogle Scholar
  26. 26.
    Abraham AS, Brooks BA, Eylath U (1992) The effects of chromium supplementation on serum glucose and lipids in patients with and without non-insulin-dependent diabetes. Metabolism 41(7):768–771. doi: 10.1016/0026-0495(92)90318-5 PubMedCrossRefGoogle Scholar
  27. 27.
    Martinez OB, MacDonald AC, Gibson RS, Bourn D (1985) Dietary chromium and effect of chromium supplementation on glucose tolerance of elderly Canadian women. Nutr Res 5(6):609–620. doi: 10.1016/S0271-5317(85)80241-4 CrossRefGoogle Scholar
  28. 28.
    Evans GW (1989) The effect of chromium picolinate on insulin controlled parameters in humans. Int J Biosoc Med Res 11(2):163–180Google Scholar
  29. 29.
    Iqbal N, Cardillo S, Volger S, Bloedon LT, Anderson RA, Boston R, Szapary PO (2009) Chromium picolinate does not improve key features of metabolic syndrome in obese nondiabetic adults. Metab Syndr Relat Disord 7(2):143–150. doi: 10.1089/met.2008.0048 PubMedCrossRefGoogle Scholar
  30. 30.
    Lucidi RS, Thyer AC, Easton CA, Holden AE, Schenken RS, Brzyski RG (2005) Effect of chromium supplementation on insulin resistance and ovarian and menstrual cyclicity in women with polycystic ovary syndrome. Fertil Steril 84(6):1755–1757. doi: 10.1016/j.fertnstert.2005.06.028 PubMedCrossRefGoogle Scholar
  31. 31.
    Racek J, Trefil L, Rajdl D, Mudrova V, Hunter D, Senft V (2006) Influence of chromium-enriched yeast on blood glucose and insulin variables, blood lipids, and markers of oxidative stress in subjects with type 2 diabetes mellitus. Biol Trace Elem Res 109(3):215–230. doi: 10.1385/bter:109:3:215 PubMedCrossRefGoogle Scholar
  32. 32.
    Volpe SL, Huang HW, Larpadisorn K, Lesser II (2001) Effect of chromium supplementation and exercise on body composition, resting metabolic rate and selected biochemical parameters in moderately obese women following an exercise program. J Am Coll Nutr 20(4):293–306. doi: 10.1080/07315724.2001.10719050 PubMedCrossRefGoogle Scholar
  33. 33.
    Vrtovec M, Vrtovec B, Briski A, Kocijancic A, Anderson RA, Radovancevic B (2005) Chromium supplementation shortens QTc interval duration in patients with type 2 diabetes mellitus. Am Heart J 149(4):632–636. doi: 10.1016/j.ahj.2004.07.021 PubMedCrossRefGoogle Scholar
  34. 34.
    Cefalu WT, Rood J, Pinsonat P, Qin J, Sereda O, Levitan L, Anderson RA, Zhang XH, Martin JM, Martin CK, Wang ZQ, Newcomer B (2010) Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus. Metabolism 59(5):755–762. doi: 10.1016/j.metabol.2009.09.023 PubMedCrossRefGoogle Scholar
  35. 35.
    Wilson BE, Gondy A (1995) Effects of chromium supplementation on fasting insulin levels and lipid parameters in healthy, non-obese young subjects. Diabetes Res Clin Pract 28(3):179–184. doi: 10.1016/0168-8227(95)01097-W PubMedCrossRefGoogle Scholar
  36. 36.
    Kleefstra N, Houweling ST, Bakker SJ, Verhoeven S, Gans RO, Meyboom-de Jong B, Bilo HJ (2007) Chromium treatment has no effect in patients with type 2 diabetes in a Western population: a randomized, double-blind, placebo-controlled trial. Diabetes Care 30(5):1092–1096. doi: 10.2337/dc06-2192 PubMedCrossRefGoogle Scholar
  37. 37.
    Pei D, Hsieh CH, Hung YJ, Li JC, Lee CH, Kuo SW (2006) The influence of chromium chloride-containing milk to glycemic control of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Metabolism 55(7):923–927. doi: 10.1016/j.metabol.2006.02.021 PubMedCrossRefGoogle Scholar
  38. 38.
    Cohen J (1988) Statistical power analysis for the behavioral sciences, 2nd edn. Lawrence Erlbaum Associates, Hillsdale, NJGoogle Scholar
  39. 39.
    Gibson RS (2005) Principles of nutritional assessment, 2nd edn. Oxford University Press, New York, NYGoogle Scholar
  40. 40.
    Brown RO, Forloines-Lynn S, Cross RE, Heizer WD (1986) Chromium deficiency after long-term total parenteral nutrition. Dig Dis Sci 31(6):661–664. doi: 10.1007/BF01318699 PubMedCrossRefGoogle Scholar
  41. 41.
    Freund H, Atamian S, Fischer JE (1979) Chromium deficiency during total parenteral nutrition. JAMA 241(5):496–498. doi: 10.1001/jama.1979.03290310036012 PubMedCrossRefGoogle Scholar
  42. 42.
    Jeejeebhoy KN, Chu RC, Marliss EB, Greenberg GR, Bruce-Robertson A (1977) Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr 30(4):531–538PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of Kinesiology and Sport SciencesUniversity of MiamiCoral GablesUSA

Personalised recommendations